Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1Breast 1

Conditions

Brain Neoplasms 3Lung Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Neoplasm Metastasis 1Meningeal Carcinomatosis 1Head and Neck Neoplasms 1Glioblastoma 1Central Nervous System Neoplasms 1Breast Neoplasms, Male 1Breast Neoplasms 1

Interventions

Radiosurgery 3Docetaxel 3cediranib 2Radiotherapy 2Lapatinib 2Capecitabine 22,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 2vandetanib 1tipifarnib 1temsirolimus 1peginterferon alfa-2a 1epothilone B 1entinostat 1X-Ray Therapy 1Vorinostat 1Vinorelbine 1Trastuzumab 1Thalidomide 1Temozolomide 1Sirolimus 1SUB1 protein, human 1Phlebotomy 1Pemetrexed 1N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine 1Moxibustion 1Mental Status and Dementia Tests 1Magnetic Resonance Spectroscopy 1Irinotecan 1Interferon alpha-2 1Immunoenzyme Techniques 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Breast Neoplasms, Male × epothilone B × CNS × Clear all
NCT00450866 2014-02-28

Epothilone B in Treating Patients With CNS Metastases From Breast Cancer

Case Comprehensive Cancer Center

Phase 2 Completed
55 enrolled 12 charts
BreastCNS

Brain Neoplasms, Breast Neoplasms, Neoplasm Metastasis, Breast Neoplasms, Male, Meningeal Carcinomatosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡